XOMA Corporation (XOMA): Price and Financial Metrics

XOMA POWR Grades

• Growth is the dimension where XOMA ranks best; there it ranks ahead of 61.27% of US stocks.
• XOMA's strongest trending metric is Growth; it's been moving up over the last 177 days.
• XOMA ranks lowest in Momentum; there it ranks in the 9th percentile.

XOMA Stock Summary

• XOMA's price/sales ratio is 44.56; that's higher than the P/S ratio of 96.51% of US stocks.
• With a year-over-year growth in debt of -87.22%, XOMA CORP's debt growth rate surpasses just 1.63% of about US stocks.
• As for revenue growth, note that XOMA's revenue has grown -90.16% over the past 12 months; that beats the revenue growth of merely 1.46% of US companies in our set.
• Stocks that are quantitatively similar to XOMA, based on their financial statements, market capitalization, and price volatility, are CJJD, TASK, VINE, MEG, and EVGO.
• XOMA's SEC filings can be seen here. And to visit XOMA CORP's official web site, go to www.xoma.com.

XOMA Valuation Summary

• In comparison to the median Healthcare stock, XOMA's price/earnings ratio is 121.72% lower, now standing at -5.8.
• XOMA's price/earnings ratio has moved up 5.7 over the prior 243 months.

Below are key valuation metrics over time for XOMA.

XOMA Growth Metrics

Its 3 year cash and equivalents growth rate is now at 82.99%.
• Its year over year price growth rate is now at -42.77%.
• The year over year cash and equivalents growth rate now stands at 26.71%.

XOMA's revenue has moved up $22,116,000 over the prior 33 months.

The table below shows XOMA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	40.486	21.653	9.793
2022-06-30	40.975	22.241	9.535
2022-03-31	40.893	22.583	12.043
2021-12-31	38.16	22.678	7.787
2021-09-30	29.797	9.714	5.429
2021-06-30	29.414	10.353	10.156

XOMA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XOMA has a Quality Grade of C, ranking ahead of 66.13% of graded US stocks.
• XOMA's asset turnover comes in at 0.233 -- ranking 184th of 682 Pharmaceutical Products stocks.
• DARE, WINT, and TCON are the stocks whose asset turnover ratios are most correlated with XOMA.

The table below shows XOMA's key quality metrics over time.